source
- Novo Nordisk aims to bring triple-G obesity injection to market by 2030Novo Nordisk said it plans to launch a triple‑G obesity injection by 2030. The drug would combine agonist activity at the GLP‑1, GIP and glucagon receptors, a class that researchers believe could b…
- Mass General launches mobile vascular clinic to treat unhoused patients and prevent amputationsUnhoused individuals often face untreated vascular problems that can quickly lead to severe wounds and the risk of losing a limb. Limited access to regular medical care leaves many without timely i…